Design and docking of novel series of hybrid xanthones as anti-cancer agent to target human DNA topoisomerase 2-alpha. Bangladesh J Pharmacol [Internet]. 2014 May 5 [cited 2026 Jun. 23];9(2):208-17. Available from: https://www.banglajol.info/index.php/BJP/article/view/18180